- Bristol Myers, Nvidia say they'll build 'most powerful' AI supercomputer in pharmaBristol Myers Squibb said Monday it will build "the most advanced and energy-efficient AI" supercomputer system in the biopharma industry, deepening its relationship with Nvidia. The New Jersey-h…Endpoints · 4d ago↗ source
- Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trialA phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study scheduled to report data in October, the biotech is holding off on…Fierce Biotech · 4d ago↗ source
- Tempus buys out cancer genomics partner Personalis in $1.5 billion dealTempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed up in oncology.